What can I expect from the weight loss programs at Red Mountain Weight Loss
Commonly reported GLP-1 adverse effectsincluding nausea, vomiting, constipation, and abdominal discomfortsubstantially overlap with symptoms of an IBD flare, which may complicate safety monitoring and clinical assessment
But we now know that weight shouldn't be the only measure of success, because GLP-1 medicines will improve liver health whether or not the patient loses weight. This research was funded by grants from the Canadian Institutes of Health Research and a Sinai Health-Novo Nordisk Foundation Fund in Regulatory peptides.
In Summary it led to : A1c Reduction up to 2% Weight loss reaching 29% Reduced Liver fat Drop blood pressure by 14 points decreased inflammatory markers reduced osteoarthritis flare ups Retatrutide shows significant weight loss in obesity and knee osteoarthritis trial In the Phase 3 TRIUMPH-4 trial (68 weeks), retatrutide demonstrated unprecedented weight loss in adults with obesity and knee osteoarthritis, with participants on the highest dose (12 mg) achieving an average weight loss of 28.7% (approximately 71 lbs)
Iron, neuroinflammation and neurodegeneration